FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> GlaxoSmithKline | Pfizer | IMS Health | Medicare

Fewer U.S. patients buy Canadian drugs

Tools

The northward migration of drug buyers is slackening, according to pharmaceuticals datameister IMS Health. In 2006 U.S. customers only spent $211 on meds from Canadian pharmacies, compared with $420 million in 2005.

Once upon a time, hordes of thrifty customers finagled their way into filling prescriptions in Canada, where drugs can be as much as 40 percent cheaper. But Medicare's prescription drug benefit has cut into the business. Canadian pharmacies also raised their prices. And drug makers Pfizer and GlaxoSmithKline threatened to cut off Canadian pharmacies that catered to U.S. customers. Meanwhile, the U.S. dollar ain't what it used to be. But the saga of drug-buying on foreign markets isn't over yet. Congress is still considering opening up imports.

- read the report from the Philadelphia Inquirer

Related Articles:
Senate approves, cripples drug import bill. Report
Reimportation issue makes a comeback in Senate. Report
Canada moves to block drug exports. Report
Dems tackle Medicare drug costs. Report

More stories about GlaxoSmithKline   Pfizer   IMS Health   Medicare  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 16 + 24?
To combat spam, please solve the math question above.